top
BRAINLIFE NEWSLETTER
Volume 2, Number 13 - 29 July 2003

Volume 2
Archive


Contents


Integrative Medicine
Overall Management
Treatment

Integrative Medicine


Popiela T, Kulig J, Hanisch J, Bock PR
Influence of a complementary treatment with oral enzymes on patients with colorectal cancers--an epidemiological retrolective cohort study
Cancer Chemother Pharmacol 2001 Jul;47 Suppl:S55-63 


Taussig SJ, Szekerczes J, Batkin S
Inhibition of tumour growth in vitro by bromelain, an extract of the pineapple plant (Ananas comosus)
Planta Med 1985 Dec;(6):538-9


Taussig SJ, Batkin S
Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application. An update
J Ethnopharmacol 1988 Feb-Mar;22(2):191-203 

Tysnes BB, Maurer HR, Porwol T, Probst B, Bjerkvig R, Hoover F
Bromelain reversibly inhibits invasive properties of glioma cells
Neoplasia 2001 Nov-Dec;3(6):469-79

Vellini M, Desideri D, Milanese A, Omini C, Daffonchio L, Hernandez A, Brunelli G
Possible involvement of eicosanoids in the pharmacological action of bromelain
Arzneimittelforschung 1986;36(1):110-2 



Overall Management


MacDonald TJ, Rood BR, Santi MR, Vezina G, Bingaman K, Cogen PH, Packer RJ
Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors
Oncologist 2003;8(2):174-86, April 2003


Treatment


D'Atri S, Tentori L, Lacal PM, Graziani G, Pagani E, Benincasa E, Zambruno G, Bonmassar E, Jiricny J
Involvement of the mismatch repair system in temozolomide-induced apoptosis
Mol Pharmacol 1998 Aug;54(2):334-41

Jaeckle KA, Eyre HJ, Townsend JJ, Schulman S, Knudson HM, Belanich M, Yarosh DB, Bearman SI, Giroux DJ, Schold SC
Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study
J Clin Oncol 1998 Oct;16(10):3310-5  

Jennifer A. Quinn, M. Eileen Dolan, Anthony E. Pegg, Robert C. Moschel, James Pluda, Roger E. McLendon, James Provenzale, William Petros, Sandra Tourt-Uhlig, Jeremy N. Rich, Sridharan Gururangan, Mary L. Affronti, Waynette Buchanan, O. Michael Colvin, Elizabeth S. Stewart, Allan H. Friedman, Darell D. Bigner, Henry S. Friedman
Phase II Trial of BCNU Plus O6-Benzylguanine for Patients with Recurrent or Progressive Malignant Glioma
ASCO Proceedings, 2001 Annual Meeting, Abstract No.251


Pegg AE
Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents
Cancer Res 1990 Oct 1;50(19):6119-29 

Pourquier P, Waltman JL, Urasaki Y, Loktionova NA, Pegg AE, Nitiss JL, Pommier Y
Topoisomerase I-mediated cytotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine: trapping of topoisomerase I by the O6-methylguanine
Cancer Res 2001 Jan 1;61(1):53-8


Slancar M., Wheeler H., Cook R., Levi J., Bell D., Beith J.
Increased pulmonary toxicity with scheduling procarbazine prior to BCNU in patients with high-grade gliomas

ASCO Proceedings, 1997 Annual Meeting, Abstract No. 1459 

Dora B. Bocangel, Sydney Finkelstein, S. Clifford Schold, Kishor K. Bhakat, Sankar Mitra and Demetrius M. Kokkinakis
Multifaceted Resistance of Gliomas to Temozolomide

Clinical Cancer Research Vol. 8, 2725-2734, August 2002

bottom


HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP